Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD)
Displaying entries 3226 - 3250 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AR03
  • Cytolipin R(d18:1/20:0)
  • GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261574 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AT03
  • GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261590 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BF03
  • Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261670 1282.812543 C64H118N2O23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AA04
  • Fucalpha1-2Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261855 1253.822379 C64H119NO22
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AZ04
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261623 1253.822379 C64H119NO22
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AL04
  • Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260255 1269.817294 C64H119NO23
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AO04
  • Galbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44260279 1269.817294 C64H119NO23
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BD04
  • Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44261655 1269.817294 C64H119NO23
Diacylglycerophosphoinositolglycans LMGP15010132
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM3(19:0/18:0)
126457500 1366.762558 C64H119O28P
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AA06
  • GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • asialo-GM2(d18:1/26:0)
44260489 1204.853618 C64H120N2O18
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA06
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Lc3Cer(d18:1/26:0)
44260617 1204.853618 C64H120N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA06
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0)
44261953 1204.853618 C64H120N2O18
LMSL03001277
  • 2-O-hexadecanoyl,3-O-(2S,4S,6S,8R,10R,12R-hexamethyl)-13-O-hydroxy-triacontanoyl)-2'-sulfotrehalose
  • AC2SGL(16:0/30:0(2Me[S],4Me[S],6Me[S],8Me[R],10Me[R],12Me[R],13OH))
126457718 1194.840277 C64H122O17S
LMSL03001288
  • 2-O-octadecanoyl,3-O-(2S,4S,6S,8R,10R,12R-hexamethyl)-13-O-hydroxy-octacosanoyl)-2'-sulfotrehalose
  • AC2SGL(18:0/28:0(2Me[S],4Me[S],6Me[S],8Me[R],10Me[R],12Me[R],13OH))
126457729 1194.840277 C64H122O17S
Diacylglycerophosphoinositolglycans LMGP15010149
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:2(9Z,12Z))
126457517 1454.705833 C65H115O33P
Diacylglycerophosphoinositolglycans LMGP15010170
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:2(9Z,12Z)/14:0)
126457538 1454.705833 C65H115O33P
Gangliosides LMSP0601AM01
  • GM2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262060 141459 1355.792537 C65H117N3O26
Gangliosides LMSP0601EK01
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262828 1355.792537 C65H117N3O26
Gangliosides LMSP0601CI01
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
52931289 1371.787452 C65H117N3O27
Diacylglycerophosphoinositolglycans LMGP15010148
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(16:0/16:1(9Z))
126457516 1456.721483 C65H117O33P
Diacylglycerophosphoinositolglycans LMGP15010164
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM4(18:1(9Z)/14:0)
126457532 1456.721483 C65H117O33P
Gangliosides LMSP0601AJ07
  • GM3(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262042 84989 1262.822713 C65H118N2O21
Gangliosides LMSP0601DC02
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262573 1342.797288 C65H118N2O26
Gangliosides LMSP0601DG02
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • KDN-GM2(d18:1/18:0)
44262605 1342.797288 C65H118N2O26
Gangliosides LMSP0601DH08
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262619 1249.827464 C65H119NO21

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024